161O RESILIENT part 2: A randomized, open-label phase III study of liposomal irinotecan versus topotecan in adults with relapsed small cell lung cancer (SCLC)

作者：C.M. Rudin, A. Dowlati, Y. Chen, A.F. Navarro Mendivil, Jinneng Yang, G. Stojanovic, P. Rich, Z.G. Andric, Yi‐Long Wu, H. Chen, L. Zhang, S-C. Yeung, F.M. Benzaghou, L. Paz-Ares, P.A. Bunn · 发表于：Journal of Thoracic Oncology · 年份：2023 · DOI：10.1016/s1556-0864(23)00415-x · 被引用次数：1 · 研究领域：Lung Cancer Research Studies、Peptidase Inhibition and Analysis、Neuroendocrine Tumor Research Advances